-
Davis and colleagues report the results of a one-year, randomized, controlled clinical trial of 814 women not on estrogen therapy from 65 centers in the United States, Canada, Australia, the United Kingdom, and Sweden with hypoactive sexual desire disorder treated with transdermal testosterone, 150 or 300 µg per day, or placebo.
-
Hereditary ovarian cancer syndromes are uncommon, but are most often represented by mutation in BRCA1/2.
-
-
The authors provide a mini-primer on interstitial cystitis (IC), a condition that is known to be poorly diagnosed and treated in many circumstances.
-
Miller and colleagues, representing 29 study centers in the United States, reported the results of a Phase 2 clinical trial, assessing the impact of denosumab on bone density.
-
Older people who report memory decline or show objective evidence of cognitive impairment are more likely to develop Alzheimer's disease and other forms of dementia over time.
-
In the issue: 5-á reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.
-
This interesting study just surfaced in the British Journal of Obstetrics and Gynecology that addressed the relationship between spastic cerebral palsy (CP) and asphyxia-related causes.
-
Zaman et al randomized 340 pregnant Bangladeshi women to receive either inactivated influenza or pneumococcal polysaccharide (control group) vaccine.
-
Glinert and colleagues from Israel report the use of photodynamic therapy to successfully ablate single feto-placental implantations in rats.